Loading chart…
PRE-MARKET
Alivus Life Sciences Limited develops and manufactures active pharmaceutical ingredients in India, the United States, Europe, Japan, Russia, Brazil, South Korea, Taiwan, Canada, China, and Australia.
Alivus Life Sciences Limited (ALIVUS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ALIVUS share price is ₹1,558.70 (+3.95% today), with a market capitalisation of ₹192B and a price-to-earnings (P/E) ratio of 28.6. MarketRipple tracks the ALIVUS investment thesis, the ripple-chain impact of market events on Alivus Life Sciences Limited, and the Healthcare sector outlook.
Open
₹1,500.90
High
₹1,574.00
Low
₹1,500.90
Prev. Close
₹1,499.40
52W High
₹1,574.00
52W Low
₹819.00
Day range
₹1,500.90–₹1,574.00
52-week range
₹819.00–₹1,574.00
Volume
229K
P/E
28.6
ROE
20.2%
D/E
0.02
Margin
24.9%
Alivus Life Sciences Limited (NSE: ALIVUS) is currently trading at ₹1,558.70 (+3.95%).
Alivus Life Sciences Limited's market capitalization is ₹192B.
Alivus Life Sciences Limited's price-to-earnings (P/E) ratio is 28.6.
Alivus Life Sciences Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Alivus Life Sciences Limited currently reads strongly positive, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.